Related Experiment Video
Updated: Mar 30, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Pill Properties that Cause Dysphagia and Treatment Failure
Jeremy Fields1, Jorge T Go2, Konrad S Schulze3
1Department of Medicine, University of Iowa; Iowa City, Iowa ; McFarland Clinic, Ames, Iowa.
Half of Americans struggle to swallow pills, with large size and rough texture being common issues. This difficulty can lead to treatment non-adherence and complications, highlighting the need for easier-to-swallow medication designs.
Area of Science:
- Pharmacology and Pharmaceutics
- Patient Experience and Adherence
- Health Outcomes Research
Background:
- Pills are a common drug delivery method, but swallowing difficulties and their impact on treatment outcomes are poorly understood.
- Patient preferences for pill properties (size, shape, texture) are largely unknown.
- Understanding these factors is crucial for improving medication adherence and clinical outcomes.
Purpose of the Study:
- To assess the prevalence of swallowing difficulties with pills among Americans.
- To identify specific pill properties that contribute to swallowing problems.
- To understand patient preferences regarding pill characteristics.
Main Methods:
- Structured interviews were conducted with 99 participants in a tertiary health care center waiting room.
- Participants reported on their pill-taking habits, swallowing difficulties, and perceived causes.
- Pills of various sizes, shapes, and textures were rated for swallowing effort and preference.
Main Results:
- 83% of participants took pills daily; 54% reported difficulty swallowing at least one solid medication.
- 4% experienced serious complications (esophagitis, impaction), and 2% discontinued treatment due to swallowing issues.
- Pill size (too large or too small), rough texture, and sharp edges were common complaints; extra-large pills were widely disliked.
Conclusions:
- Half of American adults face challenges swallowing pills, impacting treatment adherence and potentially causing complications.
- Patient-reported issues highlight the need for improved pill design, with a preference for medium-sized, smooth-coated medications.
- Healthcare providers, industry, and regulatory bodies should prioritize swallowability in medication design and licensing to enhance patient outcomes.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Treatment of Constipation-Predominant IBS
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...

